AI assistant
Satellos Bioscience Inc. — Capital/Financing Update 2026
Feb 6, 2026
48203_rns_2026-02-06_a9c0f173-6eae-4e05-b946-7bd42cc5a064.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
{0}------------------------------------------------

February 5, 2026 By SEDAR+
To: Ontario Securities Commission, as Principal Regulator under the
Passport System
And to: Alberta Securities Commission
British Columbia Securities Commission
Dear Sirs/Mesdames:
Re: Prospectus Supplement dated February 5, 2026 to the Short Form Base Shelf Prospectus dated October 29, 2025 (the "Supplement")
We refer you to the Supplement relating to the offering of common shares and pre-funded warrants of Satellos Bioscience Inc.
We consent to being named on the inside cover page of the Supplement and under the heading "Legal Matters & Interests of Experts" in the Supplement, and consent to the use of our legal opinions set out under the headings "Certain Canadian Federal Income Tax Considerations" and "Eligibility for Investment", which opinions are provided as of the date of the Supplement.
We have read the Supplement and have no reason to believe that there are any misrepresentations in the information contained in the Supplement that are (i) derived from our legal opinions provided in the Supplement, or (ii) within our knowledge as a result of the services performed by us in connection with such opinions.
Yours truly,
(signed) "Stikeman Elliott LLP"